http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11286276-B2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_26da3723d11a0786897640eceb4d464f http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0fd6ef979844ec56a09e45255176595c |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J41-0088 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J41-00 |
| filingDate | 2017-04-07^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2022-03-29^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_57f6af0aa30c52f0be2b65779076b477 |
| publicationDate | 2022-03-29^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-11286276-B2 |
| titleOfInvention | Cationic steroidal antimicrobials |
| abstract | Disclosed herein are cationic steroidal antimicrobials (“CSA compounds” or “ceragenins”) and methods of making the same. Particularly advantageous methods are identified for the synthesis of CSA compounds. CSA compounds may be formulated for treating subjects with ailments responsive to CSA compounds, including but not limited to treating bacterial infections. Accordingly, some embodiments include formulations and methods of administering CSA compounds. |
| priorityDate | 2014-01-23^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Showing number of triples: 1 to 511 of 511.